Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 67

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 67
---
 of the debt crisis in Europe,
the political unrest in the Middle East and Eastern Europe as well as rumors or threats or actual terrorist attacks or conflicts in the
Middle East, Southeast Asia, Eastern Europe or other regions will impinge upon the health of the global financial system. These or other
such events could adversely affect NewGenIvf’s business, financial condition, results of operations and prospects.

There is no assurance that
the economies and social conditions of Thailand, Cambodia, Kyrgyzstan and China will meet current projections or improve in the future.
Any instability or economic downturn could have a material adverse effect on NewGenIvf’s business, financial condition, results
of operations and prospects.

Failure to comply with the terms of future financing arrangements could result in default, which could have an adverse effect on NewGenIvf’s cash flow and liquidity.

NewGenIvf may from time to
time enter into credit facilities and debt financing arrangements containing financial and other covenants that could, among other things,
restrict NewGenIvf’s business and operations. If NewGenIvf breaches any of these covenants, including the failure to maintain certain
financial ratios, NewGenIvf’s lenders may be entitled to accelerate NewGenIvf’s debt obligations. Any default under the credit
facility could result in the repayment of these loans prior to maturity as well as the inability to obtain additional financing, which
in turn may have a material adverse effect on NewGenIvf’s cash flow and liquidity.

<div align='center'>38</div>

NewGenIvf requires a significant amount of capital to fund its operations and growth. If NewGenIvf cannot obtain sufficient capital on acceptable terms, its business, financial condition, and prospects may be materially and adversely affected.

NewGenIvf requires a significant
amount of capital and resources for its operations and continued growth. NewGenIvf expects to make significant investments to fund operations,
laboratory upgrades, new strategic investments in Solana and residential property development in United Arab Emirates, among other things,
which may significantly increase NewGenIvf’s net cash used in operating activities. In addition, NewGenIvf will continue to invest
in laboratory and facilities which are fundamental to NewGenIvf’s business operation and future growth. However, NewGenIvf cannot
assure you that these investments will generate the optimal returns, if at all. To date, NewGenIvf has historically funded its cash requirements
primarily through operational, capital contributions from its shareholders and